New review highlights top strategies for smoking cessation

A major new scientific review of evidence published in the journal Addiction has identified three top strategies for quitting smoking.

Boehringer seeks approval for lung fibrosis drug following Phase III win

Boehringer’s nerandomilast is a preferential inhibitor of phosphodiesterase 4B (PDE4B). Image credit: Tada Images / Shutterstock. Boehringer Ingelheim is seeking regulatory approval for nerandomilast after

September 16, 2024

The worst for Dexcom may not be over

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve made

July 26, 2024

Cano Health Emerges from Chapter 11, Focused on Florida Market

What You Should Know: – Cano Health, a value-based primary care provider, announced today that it has successfully exited Chapter 11 bankruptcy as a reorganized

July 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.